Schistosomiasis Diagnosis Using a CAA Antigen Test (FreebiLyGAB)
Prospective, Observational Study to Assess the Performance of CAA Measurement as a Diagnostic Tool for the Detection of Schistosoma Haematobium Infections in Pregnant Women and Their Newborn and Child in Lambaréné, Gabon
Sponsor: Centre de Recherche Médicale de Lambaréné
A PHASE3 clinical study on Diagnostic and Drug Reaction, this trial is ongoing. The trial is conducted by Centre de Recherche Médicale de Lambaréné and has accumulated 9 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Aug 2023 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Sep 2021 — Aug 2023 [monthly]
Recruiting PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE3
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Aug 2019 — Nov 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Mar 2019 — Aug 2019 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2019 — Mar 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre de Recherche Médicale de Lambaréné
- Universität Tübingen
For direct contact, visit the study record on ClinicalTrials.gov .